ArticlePloS one2017

BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells.

Marco Carretta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.